Meta-analysis of the Efficacy and Safety of Adjunctive Rosuvastatin for Dyslipidemia in Patients with Schizophrenia

BACKGROUND: Metabolic syndrome in patients with schizophrenia is a major health concern. The efficacy and safety of adjunctive rosuvastatin in treating dyslipidemia were controversial. AIMS: To assess the efficacy and safety of adjunctive rosuvastatin for dyslipidemia in patients with schizophrenia....

Descripción completa

Detalles Bibliográficos
Autores principales: UNGVARI, Gabor S., NG, Chee H., De HERT, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shanghai Municipal Bureau of Publishing 2018
Materias:
Systematic Review and Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925598/
https://www.ncbi.nlm.nih.gov/pubmed/29719353
http://dx.doi.org/10.11919/j.issn.1002-0829.217156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925598/
https://www.ncbi.nlm.nih.gov/pubmed/29719353
http://dx.doi.org/10.11919/j.issn.1002-0829.217156

Ejemplares similares